At first glance, studying the parasite that causes African sleeping sickness does not necessarily seem like an obvious path to studying the causes of cancer in humans. But for Hamed Najafabadi, PhD, there is a common thread. After earning his PhD at 平特五不中, he went to University of Toronto for a post-doctoral fellowship in new machine learning approaches. 鈥淲hen I look back, it鈥檚 very interesting how everything in my work connected to the regulation of RNA,鈥 he says. 鈥淚 transferred the same kinds of methods and techniques that I was using to understand the biology of a parasite to understanding the biology of the human cell.鈥
Since joining 平特五不中 in 2016, where he is now an Associate Professor in the Department of Human Genetics and the Principal Investigator of the Computational and Statistical Genomics lab at the recently named Victor Phillip Dahdaleh Institute of Genomic Medicine, Prof. Najafabadi and his team have been looking at the regulation of RNA in human cells to understand the causes of diseases, in particular the causes of cancer. 鈥淲hat we want to understand is how malfunctions in production of RNA lead to cancer, how it contributes to the progression of cancer, and what factors are driving this malfunction.鈥
Looking for patterns
Prof. Najafabadi鈥檚 lab uses computational and statistical frameworks to understand patterns in RNA, including the kind of patterns the cell recognizes in RNA in order to make a decision about where it goes and what it does. 鈥淯sing genomics technologies, we can track and measure tens of thousands of RNAs in various models of human diseases and also patient samples, and then use artificial intelligence and statistical methods to find patterns that can tell us what happens in the cancer cell,鈥 explains Prof. Najafabadi. They focus on RNA for two key reasons: RNA has an important functional role in the cell, and it serves as a 鈥渨indow鈥 to understand all other aspects of the cell.
Prof. Najafabadi says that beyond the basic science goal of understanding how a cell works and what causes human diseases, the ability to understand patterns that help diagnose or prognose human disease is promising. He uses the example of immunotherapies for cancer patients and how responses can differ from one person to the next. 鈥淭he question for us is, can we predict this response based on, for example, the composition of RNA molecules within cancer cells? If so, can we propose better treatments for a patient?鈥 Prof. Najafabadi says they hope to continue to improve their analytical tools in ways that will help determine which available treatment option may work best for a particular patient.
His lab鈥檚 other goal is to identify new targets for developing new therapies. 鈥淚f we can identify RNA molecules that do not work the way they should and figure out how we can restore their normal function, then this can become a potentially novel therapeutic approach,鈥 he says.
Bringing it all together
Prof. Najafabadi sees incredible opportunities with the new Centre for RNA Sciences. 鈥溒教匚宀恢 has many researchers that are really strong in RNA sciences,鈥 he says. 鈥淧eople who are world-renowned in the biology of RNA, experts in machine learning and computational biology of RNA, and experts in synthetic RNA molecules, are just some examples.鈥 Prof. Najafabadi had a lightbulb moment when he read a preliminary document for the Centre鈥檚 launch. 鈥淚 realized there are many, many more people working in this field at 平特五不中 than I knew, so the Centre is a great way to connect them and provide concentrated resources to help them develop research programs and training programs together.鈥
In describing his hope for the Centre鈥檚 success, he refers to a familiar expression. 鈥淚 think the idea is that the whole is greater than the sum of the parts, and I鈥檓 optimistic this is what the RNA Centre is going to achieve.鈥